$AIZ

DiRienzo Dimitry sold $511K of AIZ

DiRienzo Dimitry (SVP, CAO, Controller) sold 2,000 shares of ASSURANT, INC. (AIZ) at $255.68 ($0.51M total) on 2026-05-26.

Original reporting
SEC EDGAR · DiRienzo Dimitry
Published May 27, 2026, 8:27 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 27, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AIZ
Neutral
high confidence
Mentioned
$AIZ
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIZNeutralLow
01

Why it matters

Because it lacks any accompanying operational or financial update, the disclosure mainly affects short-term sentiment and positioning rather than fundamentals.

02

Market read

Traders may monitor insider-selling optics, but there is no direct evidence of a new business driver for AIZ in this filing.

03

What to watch

Check for additional Form 4 activity around the same period (multiple sales, changes in ownership trends) to assess whether this is isolated or part of a broader reduction.

Relevance 6/10Timing: Same-day/next-session positioning may be marginally affected by insider-selling optics.

Background

The article is an SEC Form 4 insider transaction disclosure for Assurant (AIZ), reporting an open-market sale by an SVP/CAO/Controller.

Company-level read

Ticker impact

$AIZNeutralHigh confidence
Context

Assurant (AIZ) disclosed an officer open-market sale: DiRienzo Dimitry sold 2,000 shares for ~$511K on 2026-05-26.

Expected impact

Low probability of sustained price impact; any reaction is likely brief and sentiment-driven.

Evidence & confidence

The filing is a Form 4 open-market sale with no 10b5-1 plan and no accompanying company-specific news (earnings, guidance, deal, litigation).

Market effects

Minimal; this is company-specific insider activity rather than a sector-wide development.

None indicated.

None indicated.

Counterpoint

No 10b5-1 plan is noted, but insider sales can still be routine (taxes, diversification) and often do not predict performance absent follow-on disclosures.

Key entities

  • Assurant, Inc.

    Subject of the Form 4 insider transaction; officer sold 2,000 shares for ~$511K.

  • DiRienzo Dimitry

    SVP, CAO, Controller who executed the reported open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AIZMedAI 8/10

Do Wall Street Analysts Like Assurant Stock?

Assurant (AIZ) stock has risen 34.7% over the past year, outperforming the S&P 500. Q2 2026 revenue was $3.5B, up 6.9% YoY, with adjusted EPS of $6.41. Analysts expect 11.5% EPS growth for the year. Nine analysts rate it 'Strong Buy,' with a mean price target of $321.43, implying 11.4% upside.

$AIZMedAI 8/10

Assurant (AIZ) Q2 2026 Earnings Call Transcript

Assurant (AIZ) reported Q2 2026 results in an earnings call transcript. Adjusted EBITDA excluding catastrophes rose 18% to $491.4M, and adjusted EPS excluding catastrophes grew 19% to $6.60. Net earned premiums, fees and other income increased 9% to $3.32B. The company revised full-year adjusted EBITDA guidance to mid-single-digit growth and reported $911M liquidity plus $75M Q2 share repurchases.

$AIZMedAI 8/10

Why Assurant (AIZ) Stock Is Trading Up Today

Assurant (AIZ) shares rose about 6.3% after the company reported Q2 2026 results that beat Wall Street. Adjusted EPS was $6.41, above the $5.18 estimate, and up 23.7% year over year. Revenue increased 9.5% to $3.45 billion. Pre-tax margin rose to 10.9%.

$AIZMed

Assurant: Q2 Earnings Snapshot

Assurant Inc. (AIZ) reported Q2 profit of $298.6 million, or $5.95 per share. Adjusted earnings were $6.41 per share versus Zacks’ estimate of $5.16. Revenue was $3.45 billion, with adjusted revenue $3.46 billion versus $3.4 billion expected. Shares were $281.31 at Tuesday’s close.